CD200R1 modulates myelin phagocytosis and spleen response following spinal cord injury
Posted by Ernesto on Wednesday, 18 February 2026
Autores:
Bruno Pannunzio 1 2 , Fabio Andrés Cawen 1 3 4 , Frances Evans 1 2 , Rubèn López-Vales 5 6 , Hugo Peluffo 1 3 4 , Natalia Lago 7 8 9
Revista (o libro):
Sci Re
Año:
2026
Mes-dia:
1120
issue, vol, paginas, etc:
15(1):41013
doi:
10.1038/s41598-025-24827-6
PMID:
41266433
Abstract:
The interaction between CD200 and its receptor CD200R1 plays a key role in modulating immune responses in nervous system disorders. This study explored the function of CD200R1 in local and systemic inflammation following spinal cord injury (SCI) using CD200R1-knockout (CD200R1-/-) mice. Following a low thoracic contusion injury, CD200R1-/- mice exhibited increased macrophage infiltration at the injury site, with a greater proportion of pro-inflammatory Ly6C + macrophages. Myelin phagocytosis was impaired in CD200R1-/- macrophages both ex vivo and in vitro, indicating a reduced capacity to clear myelin debris. Despite these immune alterations, CD200R1 deficiency did not affect spontaneous locomotor recovery post-SCI, as measured by the Basso Mouse Scale. However, CD200R1-/- mice tended to lose more weight after injury, suggesting systemic effects. In uninjured (naïve) conditions, CD200R1-/- mice showed reduced spleen weight and lymphocyte counts, along with lower mRNA expression of inflammatory cytokines TNFα, IL6, and CCL2, though no significant differences were seen in splenic immune cell populations. Altogether, these results suggest that CD200R1 is an important factor regulating myelin phagocytosis by macrophages and maintaining normal immune and splenic homeostasis under both injured and naïve conditions.
Afiliaciones:
1 Institut Pasteur de Montevideo, Montevideo, Uruguay.
2 Histology and Embryology Department, Faculty of Medicine, Universidad de la República, Montevideo, Uruguay.
3 Unitat de Bioquímica i Biologia Molecular, Departament de Biomedicina, Facultat de Medicina i Ciències de la Salut, Universitat de Barcelona (UB), Barcelona, 08036, Spain.
4 Institut de Neurociències, Universitat de Barcelona (UB), Barcelona, 08036, Spain.
5 Departament de Biologia Cel·lular, Fisiologia i Immunologia, Institut de Neurociències, Universitat Autònoma de Barcelona, Bellaterra, 08193, Spain.
6 Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (CIBERNED), Madrid, Spain.
7 Institut Pasteur de Montevideo, Montevideo, Uruguay. Natalia.Lago@uab.cat.
8 Departament de Biologia Cel·lular, Fisiologia i Immunologia, Institut de Neurociències, Universitat Autònoma de Barcelona, Bellaterra, 08193, Spain. Natalia.Lago@uab.cat.
9 Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (CIBERNED), Madrid, Spain. Natalia.Lago@uab.cat.
Enlace pubmed:
https://pubmed.ncbi.nlm.nih.gov/41266433/
Enlace full text:
https://doi.org/10.1038/s41598-025-24827-6
PDF:
http://www.histoemb.fmed.edu.uy/sites/www.histoemb.fmed.edu.uy/files/articulos/Pannunzio%202025.pdf
Cita:
Pannunzio B, Cawen FA, Evans F, López-Vales R, Peluffo H, Lago N. CD200R1 modulates myelin phagocytosis and spleen response following spinal cord injury. Sci Rep. 2025 Nov 20;15(1):41013. doi: 10.1038/s41598-025-24827-6. PMID: 41266433; PMCID: PMC12634686.